Status:
COMPLETED
Delayed Cord Clamping for Congenital Diaphragmatic Hernia
Lead Sponsor:
Children's Hospital of Philadelphia
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Congenital Diaphragmatic Hernia
Eligibility:
All Genders
1-1 years
Phase:
NA
Brief Summary
Congenital diaphragmatic hernia (CDH) is a congenital anomaly associated with a high risk of mortality and need for life-saving interventions such as extracorporeal membrane oxygenation (ECMO), nitric...
Detailed Description
Congenital diaphragmatic hernia (CDH) is a congenital anomaly associated with a high risk of mortality (29%) and need for life-saving interventions such as ECMO (33%), nitric oxide (62%), and vasopres...
Eligibility Criteria
Inclusion
- Antenatal diagnosis of CDH, with care in the Center for Fetal Treatment
- Gestational age ≥ 36 weeks at birth
Exclusion
- Multiple gestation
- Major anomalies or aneuploidy
- Enrolled in fetal endoluminal tracheal occlusion (FETO) trial
- Palliative care planned or considered
- Maternal diagnosis placenta previa, accreta, or abruption
- Maternal diagnosis pre-eclampsia requiring Magnesium sulfate therapy at time of delivery
- Obstetrics (OB) or Neonatal provider concerns for the clinical care of the mother or infant, or study team not available
Key Trial Info
Start Date :
October 12 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 9 2018
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT03314233
Start Date
October 12 2017
End Date
October 9 2018
Last Update
January 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States, 19104